Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis -: An economic evaluation

被引:95
作者
van den Belt, AGM
Bossuyt, PMM
Prins, MH
Gallus, AS
Büller, HR
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Ctr Haemostas Thrombos Atheroscler & Inflamm Res, NL-1100 DE Amsterdam, Netherlands
[3] Flinders Med Ctr, Adelaide, SA, Australia
关键词
D O I
10.1055/s-0037-1614975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two clinical trials in patients with acute deep venous thrombosis have indicated that the outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as inpatient treatment with unfractionated intravenous heparin with respect to recurrent venous thromboembolism and major bleeding. We performed an economic evaluation alongside one of these trials to assess the cost consequences of the outpatient management strategy. Data were collected through case record forms, complemented by a prospective questionnaire in 78 consecutive patients, interviews with health care providers, and hospital data bases. Our study demonstrated that seventy-five percent of patients allocated to low-molecular-weight heparin received treatment either entirely al home or after a brief hospital stay. Fifteen percent of these patients required professional domiciliary care. Within-centre comparisons of resource utilisation in terms of natural units showed that outpatient management with low-molecular-weight heparin reduced the average number of hospital days in the initial treatment period in nine centres by 59 percent (95% CI: 43 to 71 percent) accompanied by a limited increase in outpatient and professional domiciliary care. The average reduction in hospital days at the end of follow up was 40 percent (95% CI: 25 to 54 percent). A cost-minimisation analysis, focusing on resource utilisation directly related to the treatment of deep venous thrombosis and associated costs in one centre demonstrated a cost reduction of 64 percent (95% CI: 56 to 72 percent) with the outpatient management with low-molecular-weight heparin. These data suggest that outpatient management of patients with proximal venous thrombosis using low-molecular-weight heparin reduces resource utilisation and total treatment cost. Implementation should be preceded by a cautious evaluation of a potential cost shifting and organisational prerequisites.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 13 条
  • [1] DOUBILET P, 1985, MED DECIS MAKING, V9, P1229
  • [2] Drummond M F, 1991, Int J Technol Assess Health Care, V7, P561
  • [3] SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN COMPARED WITH CONTINUOUS INTRAVENOUS HEPARIN IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS
    HULL, RD
    RASKOB, GE
    PINEO, GF
    GREEN, D
    TROWBRIDGE, AA
    ELLIOTT, CG
    LERNER, RG
    HALL, J
    SPARLING, T
    BRETTELL, HR
    NORTON, J
    CARTER, CJ
    GEORGE, R
    MERLI, G
    WARD, J
    MAYO, W
    ROSENBLOOM, D
    BRANT, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (15) : 975 - 982
  • [4] Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
    Koopman, MMW
    Prandoni, P
    Piovella, F
    Ockelford, PA
    Brandjes, DPM
    vanderMeer, J
    Gallus, AS
    Simonneau, G
    Chesterman, CH
    Prins, MH
    Bossuyt, PMM
    deHaes, H
    vandenBelt, AGM
    Sagnard, L
    DAzemar, P
    Buller, HR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 682 - 687
  • [5] COSTS OF HOME CARE FOR ADVANCED BREAST AND CERVICAL-CANCER IN RELATION TO COST-EFFECTIVENESS OF SCREENING
    KOOPMANSCHAP, MA
    VANINEVELD, BM
    MILTENBURG, TEM
    [J]. SOCIAL SCIENCE & MEDICINE, 1992, 35 (08) : 979 - 985
  • [6] TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW-MOLECULAR-WEIGH HEPARINS - A METAANALYSIS
    LENSING, AWA
    PRINS, MH
    DAVIDSON, BL
    HIRSH, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (06) : 601 - 607
  • [7] A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
    Levine, M
    Gent, M
    Hirsh, J
    Leclerc, J
    Anderson, D
    Weitz, J
    Ginsberg, J
    Turpie, AG
    Demers, C
    Kovacs, M
    Geerts, W
    Kassis, J
    Desjardins, L
    Cusson, J
    Cruickshank, M
    Powers, P
    Brien, W
    Haley, S
    Willan, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 677 - 681
  • [8] LINDMARKER P, 1994, THROMB HAEMOSTASIS, V72, P186
  • [9] LOPACIUK S, 1992, THROMB HAEMOSTASIS, V68, P14
  • [10] VARIATIONS IN LENGTHS OF STAY AND RATES OF DAY CASE SURGERY - IMPLICATIONS FOR THE EFFICIENCY OF SURGICAL-MANAGEMENT
    MORGAN, M
    BEECH, R
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1990, 44 (02) : 90 - 105